Seroprevalence of community-acquired atypical bacterial pneumonia among adult COVID-19 patients from a single center in Al Madinah Al Munawarah, Saudi Arabia: A retrospective cohort study

CONCLUSION: Our study documented the seroprevalence of community-acquired bacteria co-infection among COVID-19 patients. In this study, procalcitonin was an inconclusive biomarker for non-severe bacterial co-infections among COVID-19 patients. Consideration and proper detection of community-acquired bacterial co-infection may minimize misdiagnosis during the current pandemic and positively reflect disease management and prognosis.PMID:36104051 | DOI:10.15537/smj.2022.43.9.20220379

Source: Saudi Medical Journal - September 14, 2022 Category: Middle East Health Authors: Sari T Alhoufie Nadir A Ibrahim Naif H Alsharif Khalid O Alfarouk Hatim M Makhdoom Khaled R Aljabri Sayed H Saeed Adnan A Khoumaeys Yahya A Almutawif Mustafa A Najim Hamza M Ali Alanoud A Aljifri Ali M Kheyami Areej A Alhazmi Source Type: research